StreetAlpha
Harmony Biosciences Holdings, Inc. · SEC Form 4

HRMY Insider Trading

From SEC Form 417 trades in 2 yearsUpdated Nov 20, 2026

Every open market buy and sale of Harmony Biosciences Holdings, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $6M sold.

← HRMY stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$6M7 sales · 3 insiders
Net−$6Mbought minus sold
Planned sales48%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $1.8MDec2026-01: sold $892KJanFebMarAprMayJunJulAug2026-09: sold $3.1MSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when HRMY insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an HRMY officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every HRMY insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Sep 18, 2026Kumar BudurChief Medical OfficerSale38,452$43.05$1.7M13,115Sep 18Form 4
Sep 8, 2026Kumar BudurChief Medical OfficerSale33,954$42.80$1.5M13,115Sep 9Form 4
Jan 26, 2026Sandip KapadiaCFOSale plan3,746$37.15$139K24,521Jan 28Form 4
Jan 15, 2026Sandip KapadiaCFOSale plan20,961$35.92$753K0Jan 20Form 4
Dec 12, 2025Jeffrey M. DaynoPresident, CEOSale plan25,933$40.11$1M0Dec 17Form 4
Dec 5, 2025Sandip KapadiaCFOSale plan20,000$39.54$791K0Dec 9Form 4
Nov 21, 2025Sandip KapadiaCFOSale plan3,427$35.00$120K0Nov 25Form 4
Aug 15, 2025Sandip KapadiaCFOSale plan21,573$36.50$787K0Aug 19Form 4
Apr 1, 2025Sandip KapadiaCFOSale plan6,987$32.55$227K0Apr 3Form 4
Mar 3, 2025Jeffrey DierksChief Commercial OfficerSale plan4,869$32.67$159K0Mar 5Form 4
Jan 27, 2025Sandip KapadiaCFOSale plan1,775$38.05$68K0Jan 28Form 4
Jan 27, 2025Jeffrey DierksChief Commercial OfficerSale plan14,754$37.38$552K0Jan 28Form 4
Jan 21, 2025Sandip KapadiaCFOSale plan25,000$40.18$1M0Jan 23Form 4
Jan 21, 2025Jeffrey M. DaynoPresident, CEOSale plan19,293$40.13$774K0Jan 23Form 4
Jan 21, 2025Jeffrey DierksChief Commercial OfficerSale plan30,598$37.51$1.1M0Jan 21Form 4
🔒 2 more trades. Create a free account or sign in to see them all.

HRMY insider trading FAQ

Are HRMY insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of HRMY on the open market in 0 trades, and 3 sold $6M in 7 trades, 48% of that under pre-arranged trading plans.

When did an HRMY insider last buy shares?

There has been no open market insider purchase of HRMY in the last two years.

When did an HRMY insider last sell shares?

Kumar Budur (Chief Medical Officer) sold 38,452 shares for $1.7M on Sep 18, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice